Published in Cell on March 01, 1976
Transcription of the genome of adenovirus type 12. III. Maps of stable RNA from productively infected human cells and abortively infected and transformed hamster cells. J Virol (1976) 2.12
Integration sites of adenovirus type 12 DNA in transformed hamster cells and hamster tumor cells. J Virol (1980) 1.79
Viral DNA sequences and gene products in hamster cells transformed by adenovirus type 2. J Virol (1978) 1.69
Covalently closed circles of human adenovirus DNA are infectious. EMBO J (1984) 1.49
Human adenovirus type 9-induced rat mammary tumors. J Virol (1991) 1.43
Intracellular forms of adenovirus DNA. V. Viral DNA sequences in hamster cells abortively infected and transformed with human adenovirus type 12. J Virol (1976) 1.36
Persistence of type 5 adenovirus DNA in cells transformed by temperature-sensitive mutant, H5ts125. Proc Natl Acad Sci U S A (1977) 1.23
Patterns of viral DNA integration in cells transformed by wild type or DNA-binding protein mutants of adenovirus type 5 and effect of chemical carcinogens on integration. J Virol (1980) 1.19
Adenovirus type 12-induced rat tumor cells of neuroepithelial origin: persistence and expression of the viral genome. J Virol (1980) 1.19
mRNA from the transforming segment of the adenovirus 2 genome in productively infected and transformed cells. J Virol (1976) 1.11
Analysis of human tumors and human malignant cell lines for BK virus-specific DNA sequences. Proc Natl Acad Sci U S A (1978) 1.11
Identification of adenovirus 12-encoded E1A tumor antigens synthesized in infected and transformed mammalian cells and in Escherichia coli. J Virol (1984) 1.01
Conserved primary sequences of the DNA terminal proteins of five different human adenovirus groups. Proc Natl Acad Sci U S A (1979) 0.94
Some adenovirus DNA is associated with the DNA of permissive cells during productive or restricted growth. J Virol (1978) 0.91
Adenovirus type 12 DNA sequences in primary hamster tumors. J Virol (1977) 0.91
Integration of adenovirus type 2 DNA at a limited number of cellular sites in productively infected cells. J Virol (1981) 0.91
Multiple copies of human adenovirus 12 genomes are integrated in virus-induced hamster tumors. J Virol (1977) 0.90
Isolation and characterization of four adenovirus type 12-transformed human embryo kidney cell lines. Mol Cell Biol (1984) 0.88
Do highly oncogenic group A human adenoviruses cause human cancer? Analysis of human tumors for adenovirus 12 transforming DNA sequences. Proc Natl Acad Sci U S A (1976) 0.88
Transforming DNA sequences in rat cells transformed by DNA fragments of highly oncogenic human adenovirus type 12. J Virol (1979) 0.84
Adenovirus type 12-transformed rat embryo brain and rat liver epithelial cell lines: adenovirus type 12 genome content and viral protein expression. J Virol (1982) 0.82
"sarc" sequence transcription in Moloney sarcoma virus-transformed nonproducer cell lines. J Virol (1979) 0.81
Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res (1984) 86.56
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol (1997) 29.02
Dissecting the regulatory circuitry of a eukaryotic genome. Cell (1998) 23.62
Normal and mutant human beta-globin pre-mRNAs are faithfully and efficiently spliced in vitro. Cell (1984) 12.30
Pre-mRNA splicing. Annu Rev Genet (1986) 9.86
Human beta-globin pre-mRNA synthesized in vitro is accurately spliced in Xenopus oocyte nuclei. Cell (1983) 9.77
Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature (1994) 9.37
Excision of an intact intron as a novel lariat structure during pre-mRNA splicing in vitro. Cell (1984) 9.13
Transcription activation by the adenovirus E1a protein. Nature (1989) 9.08
Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. Genes Dev (1989) 7.47
Definition of a novel promoter for the major adenovirus-associated virus mRNA. Cell (1980) 7.42
Transcriptional activation of cloned human beta-globin genes by viral immediate-early gene products. Cell (1983) 7.22
Cloning and domain structure of the mammalian splicing factor U2AF. Nature (1992) 6.55
Nucleosome disruption and enhancement of activator binding by a human SW1/SNF complex. Nature (1994) 6.55
A factor, U2AF, is required for U2 snRNP binding and splicing complex assembly. Cell (1988) 6.16
Mechanism of action of an acidic transcriptional activator in vitro. Cell (1991) 6.04
Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. Science (1995) 5.97
Facilitated binding of TATA-binding protein to nucleosomal DNA. Nature (1994) 5.95
Adenovirus DNA. I. Molecular weight and conformation. Proc Natl Acad Sci U S A (1967) 5.55
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med (1992) 5.42
Sequence-specific RNA binding by the HIV-1 Rev protein. Nature (1989) 5.36
Identification, purification, and biochemical characterization of U2 small nuclear ribonucleoprotein auxiliary factor. Proc Natl Acad Sci U S A (1989) 5.11
Binding of general transcription factor TFIIB to an acidic activating region. Nature (1991) 4.71
A specific member of the ATF transcription factor family can mediate transcription activation by the adenovirus E1a protein. Cell (1990) 4.67
A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med (1990) 4.66
A mechanism for synergistic activation of a mammalian gene by GAL4 derivatives. Nature (1990) 4.57
An adenovirus E1a protein region required for transformation and transcriptional repression. Cell (1986) 4.56
An ordered pathway of snRNP binding during mammalian pre-mRNA splicing complex assembly. EMBO J (1987) 4.52
Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B. J Natl Cancer Inst (1998) 4.43
HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA. Cell (1991) 4.43
cis and trans activation of globin gene transcription in transient assays. Proc Natl Acad Sci U S A (1983) 4.41
Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med (2000) 4.27
Risk of lung cancer associated with residential radon exposure in south-west England: a case-control study. Br J Cancer (1998) 4.24
Transcription factor ATF interacts with the TATA factor to facilitate establishment of a preinitiation complex. Cell (1988) 4.15
An RNA processing activity that debranches RNA lariats. Science (1985) 4.14
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol (1996) 4.07
The protein Sex-lethal antagonizes the splicing factor U2AF to regulate alternative splicing of transformer pre-mRNA. Nature (1993) 3.97
Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst (1996) 3.95
A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing. Gene Anal Tech (1989) 3.95
A cellular protein, activating transcription factor, activates transcription of multiple E1A-inducible adenovirus early promoters. Proc Natl Acad Sci U S A (1987) 3.91
Localization of pre-mRNA splicing in mammalian nuclei. Nature (1995) 3.88
Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell (1994) 3.86
Fake artesunate in southeast Asia. Lancet (2001) 3.84
Functional domains of adenovirus type 5 E1a proteins. Cell (1987) 3.79
Functional recognition of the 3' splice site AG by the splicing factor U2AF35. Nature (1999) 3.72
A single subunit from avian myeloblastosis virus with both RNA-directed DNA polymerase and ribonuclease H activity. Proc Natl Acad Sci U S A (1973) 3.71
A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J (1995) 3.70
GAL4 derivatives function alone and synergistically with mammalian activators in vitro. Cell (1988) 3.67
Oncogenic viruses. Annu Rev Biochem (1970) 3.65
Vancomycin susceptibility and identification of motile enterococci. J Clin Microbiol (1991) 3.61
Specific and stable intron-factor interactions are established early during in vitro pre-mRNA splicing. Cell (1985) 3.59
Biochemical characterization of U2 snRNP auxiliary factor: an essential pre-mRNA splicing factor with a novel intranuclear distribution. EMBO J (1991) 3.54
Biochemical studies on adenovirus multiplication. 18. Resolution of early virus-specific RNA species in Ad 2 infected and transformed cells. Virology (1971) 3.54
Mammalian nuclei contain foci which are highly enriched in components of the pre-mRNA splicing machinery. EMBO J (1991) 3.49
Mechanism of carcinogenesis by RNA tumor viruses. I. An RNA-dependent DNA polymerase in murine sarcoma viruses. Proc Natl Acad Sci U S A (1970) 3.47
Interaction of a common cellular transcription factor, ATF, with regulatory elements in both E1a- and cyclic AMP-inducible promoters. Proc Natl Acad Sci U S A (1988) 3.46
Expressing the human genome. Nature (2001) 3.45
A cellular transcription factor E4F1 interacts with an E1a-inducible enhancer and mediates constitutive enhancer function in vitro. EMBO J (1987) 3.45
Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc Natl Acad Sci U S A (1995) 3.28
Cryptic branch point activation allows accurate in vitro splicing of human beta-globin intron mutants. Cell (1985) 3.25
SAGA is an essential in vivo target of the yeast acidic activator Gal4p. Genes Dev (2001) 3.23
Redundant roles for the TFIID and SAGA complexes in global transcription. Nature (2000) 3.21
Eukaryotic activators function during multiple steps of preinitiation complex assembly. Nature (1993) 3.16
Interaction of U2AF65 RS region with pre-mRNA branch point and promotion of base pairing with U2 snRNA [corrected]. Science (1996) 3.15
A family of immunologically related transcription factors that includes multiple forms of ATF and AP-1. Genes Dev (1988) 3.13
The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function. Genes Dev (1991) 3.08
HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science (1993) 3.05
Transcription activation in cells lacking TAFIIS. Nature (1996) 3.04
Occupational asthma in an electronics factory. Thorax (1979) 3.03
Sequence-specific binding of transfer RNA by glyceraldehyde-3-phosphate dehydrogenase. Science (1993) 3.03
Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science (2001) 3.03
Evidence for interaction of different eukaryotic transcriptional activators with distinct cellular targets. Nature (1990) 3.03
Biochemical studies on adenovirus multiplication, XIX. Resolution of late viral RNA species in the nucleus and cytoplasm. Proc Natl Acad Sci U S A (1971) 3.02
Immunological identification of two adenovirus 2-induced early proteins possibly involved in cell transformation. Nature (1976) 3.01
A human nucleoporin-like protein that specifically interacts with HIV Rev. Nature (1995) 2.98
How different eukaryotic transcriptional activators can cooperate promiscuously. Nature (1990) 2.91
Isolation of a human papillomavirus from a patient with epidermodysplasia verruciformis: presence of related viral DNA genomes in human urogenital tumors. Proc Natl Acad Sci U S A (1982) 2.90
Interaction between an acidic activator and transcription factor TFIIB is required for transcriptional activation. Nature (1993) 2.88
The SR protein family: pleiotropic functions in pre-mRNA splicing. Trends Biochem Sci (1996) 2.88
Immunoautoradiographic detection of proteins after electrophoretic transfer from gels to diazo-paper: analysis of adenovirus encoded proteins. Proc Natl Acad Sci U S A (1981) 2.88
Multiple functional domains of human transcription factor IIB: distinct interactions with two general transcription factors and RNA polymerase II. Genes Dev (1993) 2.87
The maximal sniff in the assessment of diaphragm function in man. Clin Sci (Lond) (1985) 2.83
Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project. JAMA (1990) 2.82
Cloning and intracellular localization of the U2 small nuclear ribonucleoprotein auxiliary factor small subunit. Proc Natl Acad Sci U S A (1992) 2.82
Biochemical studies on adenovirus multiplication. IX. Chemical and base composition analysis of 28 human adenoviruses. Proc Natl Acad Sci U S A (1965) 2.79
Enhancement of TBP binding by activators and general transcription factors. Nature (1999) 2.76
Yeast TAFIIS in a multisubunit complex required for activated transcription. Nature (1994) 2.74
Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results. J Clin Oncol (2001) 2.73
Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis. Nucleic Acids Res (1989) 2.72
Controlling gene expression in living cells through small molecule-RNA interactions. Science (1998) 2.72
DNA hybridization and contour-clamped homogeneous electric field electrophoresis for identification of enterococci to the species level. J Clin Microbiol (1995) 2.69
U2AF65 recruits a novel human DEAD box protein required for the U2 snRNP-branchpoint interaction. Genes Dev (1997) 2.67
Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif. Proc Natl Acad Sci U S A (1991) 2.66
Role of the 3' splice site consensus sequence in mammalian pre-mRNA splicing. Nature (1985) 2.63
Splice site selection and ribonucleoprotein complex assembly during in vitro pre-mRNA splicing. Genes Dev (1988) 2.62
Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states. J Clin Microbiol (1993) 2.59
The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics (1997) 2.55